<DOC>
	<DOCNO>NCT00913549</DOCNO>
	<brief_summary>To demonstrate relative bioequivalency study dosage form Clemastine 2.68 mg tablet .</brief_summary>
	<brief_title>To Demonstrate Relative Bioequivalency Study Dosage Forms Clemastine 2.68 mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Clemastine</mesh_term>
	<criteria>No clinically significant abnormal find physical exam , medical history , clinical laboratory result screen . Positive test result HIV hepatitis B C. Treatment drug alcohol dependence .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Antihistamine</keyword>
</DOC>